Physician profile
Edward Law
NPI 1962459545
$1,475.86
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $562 · 2020: $196 · 2021: $193 · 2022: $209 · 2023: $283 · 2024: $33.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $316.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $425.09 | 2019-2023 | Regranex, Collagenase Santyl |
| Treace Medical Concepts, INC. | $329.30 | 2019 | |
| Integra Lifesciences Corporation | $167.75 | 2020-2022 | |
| Medtronic, INC. | $139.20 | 2023 | Venaseal |
| Kerecis Limited | $112.83 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Derma Sciences, INC. | $66.98 | 2019 | |
| Next Science LLC | $57.54 | 2020 | |
| Nevro Corp. | $47.21 | 2023-2024 | Senza |
| Zimmer Biomet Holdings, INC. | $34.99 | 2019 | |
| Tactile Systems Technology INC | $24.37 | 2019 | |
| Tei Medical INC. | $21.85 | 2019 | |
| Orthofix Medical, INC. | $18.10 | 2021 | |
| Merck Sharp & Dohme LLC | $17.10 | 2019 | |
| Organogenesis INC. | $13.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Law listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.